CL2A structure
|
Common Name | CL2A | ||
---|---|---|---|---|
CAS Number | 1846605-04-6 | Molecular Weight | 1106.22 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C51H79N9O18 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CL2ACL2A is a complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1]. |
Name | CL2A |
---|
Description | CL2A is a complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used this linker[1]. |
---|---|
Related Catalog | |
Target |
Alkyl/ether |
References |
[1]. Samantha Congreve, et al. Antibody drug conjugates (ADC). Teknisk- naturvetenskaplig fakultet |
Molecular Formula | C51H79N9O18 |
---|---|
Molecular Weight | 1106.22 |